Medical Cannula Market

Medical Cannula Market Size, Market Forecast and Outlook By FMI

Medical cannula market was valued at USD 245.2 million in 2025 and is expected to reach USD 262.1 million in 2026. Demand is forecast to reach USD 510.8 million by 2036 at 6.9% CAGR during the forecast period. Vascular access is forecast to account for 74.2% share in 2026. Hospitals are expected to represent 42.0% of end user demand in 2026.

Summary of the Medical Cannula Market

• Demand and Growth Drivers
  • IV access supports daily hospital care because patients often need fluids or medicines during treatment.
  • Airway care adds repeat demand as nasal and Guedel cannulas support oxygen therapy and anesthesia.
  • Safety-focused cannulas are gaining preference because hospitals want to reduce needlestick risk during routine use.
  • Homecare use is adding a new demand route as more patients need oxygen support outside hospital care.
• Product and Segment View
  • Vascular access holds a leading role because IV therapy is used across emergency care and general wards.
  • Nasal cannulas support respiratory care as hospitals and homecare providers need simple oxygen delivery products.
  • Guedel cannulas remain useful in airway management because they help keep the airway open during anesthesia.
  • Latex-free and silicone options are gaining attention as hospitals focus more on comfort and allergy risk.
• Geography and Competitive Outlook
  • India supports faster demand as hospital access improves and local medical device supply becomes stronger.
  • Europe maintains steady demand because public hospitals use cannulas across routine procedures and inpatient care.
  • China adds volume through large hospital networks and expanding critical care use.
  • Competition depends on safe design and reliable hospital supply because buyers need products that work consistently.
• Analyst Opinion
  • FMI Principal Consultant Sabyasachi Ghosh says, “Medical cannula buying is moving from basic availability toward safer placement and smoother workflow. Hospitals need dependable vascular access products as IV therapy touches many patient pathways. Suppliers with broad gauge coverage and training support will gain preference in high-use care settings. Clear regulatory files will support repeat approval.”
• Medical Cannula Market Value Analysis
  • Medical cannula market is moving from a basic hospital consumable space into a more safety-focused access product segment.
  • Use is rising as hospitals need reliable IV access for fluid delivery and medicine administration.
  • Market value is supported by airway care needs across oxygen therapy and anesthesia use.
  • Hospitals are placing more value on safer insertion, patient comfort, and steady product availability.

Key Takeaways, Market Size, and Forecast

Metric	Value
Market Size (2025)	USD 245.2 Million
Market Size (2036)	USD 510.8 Million
Fastest-Growing Segment	Demand
Demand CAGR	6.9%
Incremental Opportunity (2026–2036)	USD 248.7 Million
Leading Medical Procedure (2026)	Vascular Access
Vascular Access Share (2026)	74.2%
Leading End User (2026)	Hospitals
Hospitals Share (2026)	42.0%
Leading Product Type	Guedel Cannulas
Guedel Cannulas Share	27.8%
Fastest-Growing Country	India
India CAGR	8.2%
2nd Fastest-Growing Country	Spain
Spain CAGR	8.1%

Medical cannula selection is becoming more practical for hospitals as suppliers move from basic access tubes toward pressure-rated and procedure-specific devices. In March 2024, USA Food and Drug Administration’s 510(k) summary for Poly Medicure’s Nouvo Safety Set stated that 18G to 22G catheters can be used with power injectors up to 300 psi. That helps hospitals use the same IV access across infusion and imaging work. Cardiac use is becoming more size-specific.

Medtronic states that its Bio-Medicus NextGen multi-stage cannula comes in six sizes, with side-hole baskets rising from 3 at 15/17 Fr to 7 at 25 Fr. That gives cardiac centers more control during drainage and patient matching. Specialty cannulas are moving closer to therapy delivery. In November 2024, the USA Food and Drug Administration classified SmartFlow Neuro Cannula as a Class II brain intraparenchymal infusion cannula for eladocagene exuparvovec-tneq delivery in aromatic L-amino acid decarboxylase deficiency patients.

Medical Cannula Market Definition

Medical cannula market covers disposable and reusable tube-like devices inserted into a body cavity or blood vessel. Devices support fluid delivery and suction. Scope covers vascular cannulas and airway cannulas. High flow nasal cannula products and procedure-specific cannulas sold to healthcare facilities are included.

Medical Cannula Market Inclusions

Scope includes Guedel and Yankauer cannulas. Berman and Frazier cannulas are included. Intravenous cannulas and nasal cannulas are covered. Key stakeholders include hospitals and clinics. Ambulatory surgical centers and homecare providers are included.

Medical Cannula Market Exclusions

Scope excludes standalone syringes, unrelated catheters, vascular closure devices, ventilators, infusion pumps, endoscopes, guidewires, pharmaceutical fluids, and oxygen gases.

Medical Cannula Market Research Methodology

• Primary Research: FMI analysts reviewed hospital buying patterns and supplier product portfolios. Distributor feedback was checked across major healthcare countries.
• Desk Research: Public health data and regulatory notices were used for demand checks. Official company releases were reviewed for competitive activity.
• Market Sizing and Forecasting: Market size was estimated using procedure volume and product use intensity. Average selling price by material and size was used.
• Data Validation: Forecast checks compared IV access use with home respiratory therapy demand. Hospital procedure intensity was reviewed across mature and high-volume countries.

Why is the Medical Cannula Market Growing?

• Routine IV access is raising cannula use as hospitals need safe fluid and medicine delivery.
• Airway care supports repeat demand as nasal and Guedel cannulas are used in oxygen support.
• Safety-focused designs are gaining attention as hospitals reduce needlestick risk.

Medical cannula demand is rising as hospitals depend on vascular access for daily care. IV cannulas help clinicians deliver fluids and medicines quickly. In September 2024, B. Braun Medical received USA Food and Drug Administration clearance for Introcan Safety 2 Deep Access IV Catheter. The product supports longer IV access with passive needlestick protection and blood control. Such features matter in difficult vascular access cases. Hospitals are more likely to choose suppliers with safe designs and clear clinical support.

Airway and respiratory care add another steady use area for cannulas. Nasal cannulas support oxygen delivery in hospitals and homecare. AirLife lists Salter-Style oxygen nasal cannulas across adult and pediatric options. Such product depth supports use across emergency care and recovery areas. Suppliers with soft patient-contact designs can serve longer wear needs more effectively.

Market Segmentation Analysis

• Guedel cannulas are expected to account for 27.8% share in 2026.
• In 2026, vascular access is forecast to hold 74.2% share.
• 18G cannulas are anticipated to represent 24.6% share in 2026.
• Latex is expected to hold 35.0% share in the same period.
• Hospitals are forecast to take 42.0% share in 2026.

The medical cannula market is divided into groups based on product, medical procedure, size, material, end user, and region. Product includes Guedel and Yankauer cannulas. It also includes intravenous cannulas and nasal cannulas. Medical procedure covers vascular access and surgery. Intubation and respiratory procedures are included in the same scope. By size, the market covers 14G and 16G cannulas. It also includes 18G, 20G, 22G, 24G, and 26G cannulas. Material covers latex and latex-free cannulas. Plastic, polyurethane, Teflon, metal, and silicone cannulas are included. By end user, the market covers hospitals and clinics. Ambulatory surgical centers, cosmetic centers, and homecare settings complete the end user scope.

Insights into Medical Cannula Market by Product

• Guedel cannulas are forecast to hold 27.8% share in 2026 as emergency and anesthesia workflows need simple airway patency support.
• Yankauer and Frazier cannulas support suction use during surgery and ENT care. Intravenous cannulas hold broad use in medication delivery and fluid access.

Insights into Medical Cannula Market by Medical Procedure

• During 2026, vascular access is expected to account for 74.2% share with peripheral IV placement supporting fluids and medication.
• Surgery and respiratory procedures create a second route through suction and oxygen delivery. ECMO machines and cannula interfaces support complex critical care. Intubation support gives airway cannulas a steady role in acute care.

Insights into Medical Cannula Market by Size

• Emergency care keeps 18G cannulas ahead, with 24.6% share forecast in 2026.
• 20G and 22G cannulas serve routine medication delivery. Intraosseous infusion devices compete in emergency access cases. 24G and 26G sizes support pediatric use and fragile vein access.

Insights into Medical Cannula Market by Material

• Latex is expected to represent 35.0% share in 2026 through low-cost routine use across care settings.
• Latex-free and silicone cannulas gain attention for sensitive patients. Polyurethane and Teflon options support smoother insertion and longer dwell comfort.

Insights into Medical Cannula Market by End User

• Hospitals are forecast to account for 42.0% share in 2026 as inpatient care and emergency access drive bulk use.
• Clinics and day care centers support repeat demand through minor procedures. Peripheral vascular devices create related buying needs in vascular care. Homecare settings add oxygen therapy and infusion support use.

Medical Cannula Market Drivers, Restraints, and Opportunities

• Peripheral access supports medicine delivery and fluid support across emergency care and general wards.
• Latex-free and soft silicone cannulas can raise product cost for hospitals with large order volumes.
• Nasal cannulas gain demand as respiratory therapy use expands across homecare settings.

Routine IV Access Lifts Volume

Peripheral access is one of the most common steps in hospital care. Nurses and clinicians use cannulas to deliver medicines and fluids quickly. Hospitals need different sizes because patients have different vein conditions. Cannula suppliers gain preference when products support safe placement and easy handling. Better product choice can reduce repeat insertion attempts and improve daily care flow.

Material Sensitivity Adds Cost

Material choice affects patient comfort and allergy risk. Latex-free and silicone cannulas are gaining attention as hospitals focus more on safer patient contact. These options can cost more than standard products. Hospitals must balance comfort needs with large-volume buying pressure. Suppliers with clear labeling and steady material supply can reduce confusion during product selection.

Home Oxygen Use Opens Demand

Respiratory cannulas gain a wider role as oxygen therapy moves into homecare. Nasal cannulas are simple to use and support longer wear during breathing support. Fisher & Paykel Healthcare’s Optiflow therapy uses a nasal cannula to deliver heated and humidified air and oxygen. This supports demand for soft patient-contact designs. Suppliers with comfortable cannula options can serve chronic care and post-acute oxygen users.

Analysis of Medical Cannula Market by Key Countries

Country	CAGR
India	8.2%
Spain	8.1%
Italy	7.7%
France	7.5%
Canada	7.4%
United Kingdom	7.3%
China	6.7%

Source: Future Market Insights, 2026.

Medical Cannula Market CAGR Analysis by Country

• India is expected to expand at 8.2% CAGR by 2036 as public hospital access supports high-volume cannula buying.
• Spain is anticipated to rise at 8.1% CAGR during the forecast period with public hospitals managing large inpatient and consultation loads.
• Over 2026 to 2036, Italy is expected to advance at 7.7% CAGR as one-day hospital care supports routine disposable use.
• France is forecast to move ahead at 7.5% CAGR by the end of 2036 as inpatient discharge volume supports steady procedure supply needs.
• Canada is expected to advance at 7.4% CAGR over the forecast decade with acute hospitalization demand supporting steady cannula use.
• United Kingdom is expected to move at 7.3% CAGR during 2026 to 2036 as elective care recovery increases pressure on procedure supplies.
• China is expected to record 6.7% CAGR by 2036 as critical care capacity and hospital networks drive demand.

Demand Outlook for Medical Cannula Market in India

Public care access keeps India among steadily growing country markets. India is expected to expand at 8.2% CAGR through 2036 as hospital admission coverage improves. Press Information Bureau reported 11.69 crore hospital admissions authorized under Ayushman Bharat Pradhan Mantri Jan Arogya Yojana as of 28 February 2026. Larger admission coverage supports IV access and routine procedure supply demand. Local manufacturing from Hindustan Syringes & Medical Devices Ltd. and Poly Medicure gives hospitals a price-sensitive supply route.

• Delhi and Mumbai hospitals need high-volume IV cannula availability for emergency care.
• Bengaluru and Hyderabad support specialist use through oncology and critical care centers.
• Domestic suppliers can compete by pairing low cost with reliable sterilization files.

Sales Analysis of Medical Cannula Market in Spain

Spain is forecast at 8.1% CAGR through 2036. Spain’s public hospital system supports a steady order cycle for cannulas. About 3.9 million acute care hospital discharges and nearly 87.0 million medical consultations were reported in the 2023 national health system review. High public care volume supports repeat buying of IV and suction cannulas. Tender readiness and Spanish-language clinical support will guide supplier selection.

• Madrid and Catalonia create large hospital buying pools for routine cannulas.
• Public hospitals favor stable pricing and simple product documentation.
• Specialist clinics add demand for lipofilling and procedure-specific cannulas.

Future Outlook for Medical Cannula Market in Italy

Italy keeps procedure disposables in steady use through hospital and day care pathways. OECD country health analysis noted one-day hospital stays accounted for 40.0% of all hospitalizations in 2023. Short-stay care needs reliable cannulas supporting quick procedure turnover. Italy is expected to advance at 7.7% CAGR through 2036. Local tenders will favor suppliers with broad sizes and clear material labels.

• Lombardy and Lazio offer demand depth through large public hospital networks.
• Day surgery pathways support suction and vascular access product use.
• Clinics can increase use of blunt cannulas for aesthetic procedures.

Opportunity Analysis of Medical Cannula Market in France

Through 2036, France is forecast to grow at 7.5% CAGR. French buyers will expect CE-compliant files and product consistency across hospital groups. France benefits from high inpatient activity and mature hospital purchasing. France accounted for 15.5% of EU inpatient hospital discharges in 2023 according to Eurostat. Such clinical volume sustains vascular access and oxygen support demand

• Paris and Lyon support hospital demand for vascular access products.
• Public care networks create repeat tender cycles for core cannula lines.
• Specialist surgical centers need suction and procedure-specific cannulas.

Future Outlook for Medical Cannula Market in Canada

Canada’s acute care system supports repeat product use across hospitals. Canadian Institute for Health Information reported 3.14 million acute inpatient hospitalizations in 2024 to 2025. Hospital stays and surgery data guide supply planning across provinces. Demand in Canada is forecast to rise at 7.4% CAGR by 2036. Stable availability and bilingual labeling can improve hospital access.

• Ontario and Quebec is generating significant hospital demand pools for IV cannulas.
• Western provinces support emergency and respiratory care purchases.
• Homecare oxygen use can raise demand for comfortable nasal cannulas.

Demand Outlook for Medical Cannula Market in the United Kingdom

United Kingdom is expected to post 7.3% CAGR through 2036. Elective care activity supports procedure supply demand in the United Kingdom. National Health Service England reported 7.4 million referral-to-treatment pathways waiting to start treatment at the end of September 2025. Care recovery increases the need for reliable disposables across surgery and day care sites. Suppliers must support stock continuity and simple user training.

• England drives most demand through NHS hospital purchasing.
• Elective hubs can increase use of suction and vascular access cannulas.
• Private hospitals add premium demand for smoother insertion and patient comfort.

Sales Analysis of Medical Cannula Market in China

China’s hospital system adds volume through critical care and routine procedures. National health authorities continued critical care capacity work in 2024. ICU bed additions support vascular access and oxygen delivery use. China is expected to record 6.7% CAGR through 2036 as hospital networks deepen demand. Domestic and multinational suppliers will compete on price and hospital qualification depth.

• Tier-one city hospitals need advanced cannulas for high-acuity procedures.
• Provincial hospitals create volume demand for standard IV and nasal cannulas.
• Local suppliers gain with lower prices and fast distribution coverage.

Competitive Landscape and Strategic Positioning

• Competition depends on how well suppliers support vascular access in daily hospital care.
• Hospitals prefer cannulas with safe insertion, clear labeling, and reliable sterile supply.
• Airway cannula suppliers compete on patient comfort during oxygen support and anesthesia.
• Entry barriers come from regulatory clearance with clinical trust and material traceability.

Competitive positioning in the medical cannula market is strongest among suppliers with proven vascular access products. Among the key players, B B. Braun holds a strong position in IV access through safety-focused catheter design and hospital supply depth. Its Introcan Safety 2 Deep Access IV Catheter supports difficult vascular access needs and strengthens its role in high-use hospital accounts. Suppliers with similar safety proof can gain preference in high-use hospital accounts.

Teleflex improves its position through hospital purchasing access. In January 2025, Teleflex received a Vizient contract for Arrow short-term central venous catheters and arterial catheters. . Contract access can help hospitals standardize vascular access products across departments. Teleflex benefits from a broad Arrow portfolio and broad hospital reach.

Key Companies in the Medical Cannula Market

• Vascular Access Leaders: Teleflex Incorporated and B. Braun SE compete through broad catheter and cannula portfolios.
• Infusion and Hospital Supply Specialists: ICU Medical, Inc. and Poly Medicure Limited compete through hospital consumables and vascular access products.
• Respiratory and Airway Participants: Fisher & Paykel Healthcare Limited and SunMed support oxygen delivery and airway interface needs.
• India-Based Volume Supplier: Hindustan Syringes & Medical Devices Ltd. supports cost-sensitive IV cannula demand.

Competitive Benchmarking: Medical Cannula Market

Company	Vascular Access Breadth	Airway Interface Depth	Regulatory Support	Geographic Footprint
Teleflex Incorporated	High	Medium	High	Global with USA strength
B. Braun SE	High	Low	High	Europe and global hospital reach
ICU Medical, Inc.	Medium	Low	High	North America and global infusion base
Poly Medicure Limited	Medium	Medium	Medium	India-centered export network
Fisher & Paykel Healthcare Limited	Low	High	High	Global respiratory care base
Hindustan Syringes & Medical Devices Ltd.	Medium	Low	Medium	India-centered supply base
SunMed	Low	High	Medium	North America respiratory care base

Source: Future Market Insights competitive analysis, 2026.

Key Developments in Medical Cannula Market

• In September 2024, B. Braun Medical received FDA clearance for Introcan Safety 2 Deep Access IV Catheter. Clearance supports longer-length IV access products with passive needlestick protection.
• In July 2025, Teleflex completed the acquisition of BIOTRONIK’s Vascular Intervention business. Deal completion adds vascular product depth and expands interventional access reach.

Key Players in the Medical Cannula Market

Major Global Players

• Teleflex Incorporated
• B. Braun SE
• ICU Medical, Inc.
• Fisher & Paykel Healthcare Limited

Regional and Volume Suppliers

• Poly Medicure Limited
• Hindustan Syringes & Medical Devices Ltd.
• SunMed

Procedure-Focused Participants

• AdvaCare Pharma
• JCM MED
• Medline Industries, LP

Medical Cannula Market Report Scope

Parameter	Details
Quantitative Units	USD 245.2 million to USD 510.8 million at 6.9% CAGR
Market Definition	Cannulas used for vascular access and airway support. Scope covers suction and oxygen delivery. Selected surgical procedures are included.
Regions Covered	North America and Latin America. Europe and East Asia. South Asia and Pacific.
Countries Covered	India and Spain. Italy and France. Canada and United Kingdom. China and 30 additional countries.
Key Companies Profiled	Teleflex Incorporated and B. Braun SE. ICU Medical, Inc. and Poly Medicure Limited. Fisher & Paykel Healthcare Limited, Hindustan Syringes & Medical Devices Ltd., and SunMed.
Forecast Period	2026 to 2036
Approach	Hybrid bottom-up and top-down method using procedure use intensity and cannula value per care episode.

Medical Cannula Market by Segments

By Product

• Guedel
• Yankauer
• Berman
• Frazier
• Spackmann
• Barron
• Novak
• Poole
• Robertazzi
• Bellucci
• Brackman
• Karman
• Intravenous Cannula
• Nasal Cannula
• Others

By Medical Procedure

• Vascular Access
• Surgery
• Intubation
• Lipofilling
• Suction
• Irrigation
• Biopsy
• Insufflation
• Hysterography
• Insemination
• Cardioplegia
• Respiratory Procedures
• Cardiac Surgery Procedures

By Size

• 14G
• 16G
• 18G
• 20G
• 22G
• 24G
• 26G

By Material

• Latex
• Latex-Free
• Neoprene
• Plastic Cannula
• Polyurethane Cannula
• Teflon Cannula
• PVC Components
• Metal Cannula
• Stainless Steel Cannula
• Titanium Cannula
• Silicone Cannula

By End User

• Hospitals
• Public Hospitals
• Private Hospitals
• Clinics
• Day Care Clinics
• Specialty Clinics
• Ambulatory Surgical Centers
• Outpatient Surgery Centers
• Cosmetic Centers
• Homecare Settings
• Home Infusion Users
• Other

By Region

• North America
  • United States
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Europe
  • Spain
  • Italy
  • France
  • Germany
  • United Kingdom
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • Australia
  • ASEAN
• Middle East and Africa
  • GCC
  • South Africa
  • Turkey

Research Sources and Bibliography

• Food and Drug Administration. (2024, August 16). Medical devices; general hospital and personal use devices; classification of the intravenous catheter force-activated separation device. Federal Register.
• B. Braun Medical Inc. (2024, September 24). B. Braun Medical receives FDA clearance for Introcan Safety® 2 Deep Access IV Catheter. B. Braun.
• Press Information Bureau. (2026, March 23). Update on AB-PMJAY. Ministry of Health and Family Welfare, Government of India.
• Ministerio de Sanidad. (2023). Annual report on the National Health System of Spain, 2023: Executive summary. Gobierno de España.
• OECD & European Observatory on Health Systems and Policies. (2025). Country health profile 2025: Italy. OECD Publishing.
• Eurostat. (2025, December). Hospital discharges and length of stay statistics. European Commission.
• Canadian Institute for Health Information. (2026, February 19). Hospital stays in Canada, 2024-2025. Canadian Institute for Health Information.
• NHS England. (2025, November 13). NHS referral to treatment waiting times data: September 2025. NHS England.
• National Medical Products Administration. (2024, May 7). China moves to improve critical care medical services. National Medical Products Administration.
• Teleflex Incorporated. (2025, January 9). Teleflex awarded Short Term Central Venous Catheters contract from Vizient. Teleflex Incorporated.
• Teleflex Incorporated. (2025, July 1). Teleflex completes acquisition of BIOTRONIK’s Vascular Intervention business. Teleflex Incorporated.

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.

This Report Answers

• What is the current size of the medical cannula market and how much value can suppliers address by 2036?
• Which medical procedure segment is expected to hold the leading share in 2026?
• Which end user group is forecast to create the main buying pool for cannulas?
• Which countries are expected to advance faster during the forecast period?
• How do product size and material choices affect hospital purchasing decisions?
• Which companies are active and valid in vascular access and airway cannula supply?
• What official developments support competition in IV access and respiratory cannula products?
• How does FMI size the market using procedure use intensity and average product value?